Marker Therapeutics, Inc. (MRKR)

2.18 +0.06 (+2.83%) USD  |  NASDAQ  |  Jan 21, 16:00
2.13 -0.05 (-2.29%) After-Hours: 18:52
More

Marker Therapeutics Tobin's Q (Approximate) (Quarterly)

Tobin's Q (Approximate) (Quarterly) Chart

View Tobin's Q (Approximate) (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Tobin's Q (Approximate) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years

View Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Tobin's Q (Approximate) (Quarterly) Benchmarks

View Tobin's Q (Approximate) (Quarterly) Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade